David Autry, Alan Alyas and Vii Bishop are the first recipients of the new scholarship.
David Autry, Alan Alyas and Vii Bishop are the first recipients of the new scholarship.
David Autry, Alan Alyas and Vii Bishop are the first recipients of the new scholarship.
David Autry, Alan Alyas and Vii Bishop are the first recipients of the new scholarship.
Okere, who works as a senior director at Nurix Therapeutics, has built a career in pharmacovigilance and drug safety.